<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 59-year-old Japanese woman, diagnosed with <z:e sem="disease" ids="C0026272" disease_type="Disease or Syndrome" abbrv="MCTD">mixed connective tissue disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e>) and <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), developed several characteristic features of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) after receiving alpha-interferon (IFN-alpha) </plain></SENT>
<SENT sid="1" pm="."><plain>She displayed recurrent oral <z:e sem="disease" ids="C0038363" disease_type="Disease or Syndrome" abbrv="">aphtha</z:e>, <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulceration</z:e>, <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum at the bilateral arm, and <z:hpo ids='HP_0011134'>low grade fever</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The skin of the femur where the IFN-alpha was injected showed modular acneiform changes </plain></SENT>
<SENT sid="3" pm="."><plain>Skin biopsy revealed perivascular infiltration </plain></SENT>
<SENT sid="4" pm="."><plain>The symptoms compatible with BD improved after discontinuation of IFN-alpha and the introduction of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="2" ids="2948">azathioprine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>This is the first description of BD induced by IFN-alpha </plain></SENT>
</text></document>